On Thursday, a Federal Circuit panel critically examined Masimo’s challenge to overturn Patent Trial and Appeal Board decisions which invalidated ten patents that Masimo had asserted against Apple. These patents centered around the technology used for measuring blood oxygen levels. In the course of the justification, one judge indicated that the board’s intricate findings might warrant consideration and respect.
For more in-depth information and further developments, please refer to the full article on Law360.